Pellets made of Microcristalline Cellulose for retard formulations and innovative drug delivery.
According to monographs of Microcrystalline Cellulose (Ph. Eur., USP-NF). DMF N° 18519 since July 15, 2005.
Homogeneous distribution & controlled release
A homogeneous distribution of the active agend and the controlled release are two fundamental advantages of this dosage form.
Multiple dosage form mean more reliable formulations thanks to the homogeneous concentration of highly active agents. CELLETS® support this pioneering development. We can supply this innovative pellet in almost any particle size starting from 100 µm micropellets.